To investigate whether clusterin may also be involved in mediating synaptic tau pathology, we immunostained array tomography ribbons from PSP and control frontal cortex with antibodies against postsynapses (PSD95), oligomeric tau (T22) and clusterin (Fig. 6a). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.